SCHEMBL2660490

SCHEMBL2660490

NC(=O)c1cccc(-c2cc[nH]n2)c1Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.47
BCAT2 O15382 1/20 0.43
CHEK2 O96017 1/20 0.42
BRD4 O60885 3/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
AURKA O14965 1/20 0.40
RPS6KB1 P23443 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PARP1 P09874 2/20 0.39
CSNK1A1 P48729 1/20 0.39
TYRO3 Q06418 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
PARP10 Q53GL7 1/20 0.39
MAPK8 P45983 1/20 0.37
MAPK10 P53779 1/20 0.37
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
KEAP1 Q14145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3418710 0.82 PARP1 (0.41) BCAT2PARP1CSNK1A1TYRO3DYRK1B
SCHEMBL30528245 0.81 BCAT2 (0.55) CTNNB1BCAT2PARP1CSNK1A1TYRO3
SCHEMBL696661 0.81 BCAT2 (0.55) CTNNB1BCAT2PARP1CSNK1A1TYRO3
SCHEMBL30528244 0.81 BCAT2 (0.55) CTNNB1BCAT2PARP1CSNK1A1TYRO3
SCHEMBL28081509 0.79 BCAT2 (0.61) CTNNB1BCAT2CHEK2BRD4SIRT2
SCHEMBL5117078 0.79 BCAT2 (0.51) CTNNB1BCAT2PARP1CSNK1A1TYRO3
SCHEMBL3423724 0.77 BCAT2 (0.42) BCAT2AURKAPARP1CSNK1A1TYRO3
SCHEMBL3418979 0.76 BCAT2 (0.41) BCAT2CHEK2AURKAPARP1CSNK1A1
SCHEMBL7159631 0.76 BCAT2 (0.41) BCAT2BRD4AURKAPARP1CSNK1A1
SCHEMBL7159727 0.76 BCAT2 (0.41) BCAT2BRD4AURKAPARP1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756076-A1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2007-02-28 EP disclosed
WO-2005121110-A1 HETROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2005-12-22 WO disclosed